Funding for this research was provided by:
Canadian Institutes of Health Research (Fredrick Banting and Charles Best Canada Graduate Scholarship, Foundation award)
Heart and Stroke Foundation of Canada (G-15-0009214)
Genome Canada (Genome Quebec)
Received: 11 June 2019
Accepted: 23 January 2020
First Online: 10 February 2020
Ethics approval and consent to participate
: Patients provided informed, signed consent with ethics approval from the Western University ethics review board (#07290E).
: Not applicable.
: R.A.H. reports consulting fees from Acasti, Aegerion, Akcea/Ionis, Amgen and Sanofi. The other authors have no disclosures.